Real-time enrollment status for this major depressive disorder with excessive daytime sleepiness symptoms clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 7:12 PM UTC
| NCT Number | NCT07484217 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms |
| Phase | PHASE3 |
| Target Enrollment | 508 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Axsome Therapeutics, Inc. |
| Last Updated on CT.gov | October 13, 2026 (19 hours ago) |
As of October 13, 2026: Clinical trial NCT07484217 is currently recruiting participants. This phase3 study for major depressive disorder with excessive daytime sleepiness symptoms is actively seeking new participants at 40 locations across the United States. The study is sponsored by Axsome Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07484217 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07484217 was last updated 19 hours ago (October 13, 2026). HelloStudys verifies this status automatically.